2215 Stock Overview
Researches and develops, produces, and sells agricultural inputs in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Shenzhen Noposion Crop Science Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.22 |
| 52 Week High | CN¥10.04 |
| 52 Week Low | CN¥5.65 |
| Beta | 0.47 |
| 1 Month Change | 4.71% |
| 3 Month Change | 5.66% |
| 1 Year Change | 9.31% |
| 3 Year Change | 47.31% |
| 5 Year Change | 6.48% |
| Change since IPO | -20.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2215 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | -3.7% | -3.7% | -2.8% |
| 1Y | 9.3% | -16.4% | -11.7% |
Return vs Industry: 002215 exceeded the CN Chemicals industry which returned -16.5% over the past year.
Return vs Market: 002215 exceeded the CN Market which returned -10.5% over the past year.
Price Volatility
| 2215 volatility | |
|---|---|
| 2215 Average Weekly Movement | 6.5% |
| Chemicals Industry Average Movement | 7.2% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in CN Market | 10.5% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 002215 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002215's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 3,693 | Huansen Gao | www.noposion.com |
Shenzhen Noposion Crop Science Co., Ltd. researches and develops, produces, and sells agricultural inputs in China and internationally. It offers pesticide preparations and plant nutrition products; and agricultural services.
Shenzhen Noposion Crop Science Co., Ltd. Fundamentals Summary
| 2215 fundamental statistics | |
|---|---|
| Market cap | CN¥8.20b |
| Earnings (TTM) | CN¥471.55m |
| Revenue (TTM) | CN¥4.60b |
17.4x
P/E Ratio1.8x
P/S RatioIs 2215 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2215 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.60b |
| Cost of Revenue | CN¥3.04b |
| Gross Profit | CN¥1.56b |
| Other Expenses | CN¥1.09b |
| Earnings | CN¥471.55m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.47 |
| Gross Margin | 33.85% |
| Net Profit Margin | 10.25% |
| Debt/Equity Ratio | 84.3% |
How did 2215 perform over the long term?
See historical performance and comparison